Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | EGLN2 | Q96KS0 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | HAVCR2 | Q8TDQ0 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119203 | 0.94 | TSHR (0.50) | TSHRALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL5945887 | 0.91 | TSHR (0.48) | TSHRALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL10098510 | 0.88 | TSHR (0.46) | TSHRALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL30394200 | 0.88 | TSHR (0.50) | TSHRALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL8954330 | 0.88 | TSHR (0.50) | TSHRALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL30702008 | 0.85 | TSHR (0.39) | TSHRALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL1343876 | 0.85 | TSHR (0.39) | TSHRALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL20444047 | 0.83 | TSHR (0.42) | TSHRALDH1A1KMT2AL3MBTL1EGLN2 | |
| Bicarbonate SCHEMBL11599443 | 0.81 | TSHR (0.41) | TSHRALDH1A1KMT2AL3MBTL1POLB | |
| SCHEMBL6322423 | 0.81 | TSHR (0.41) | TSHRALDH1A1KMT2AMEN1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534685-B2 | Fragrance composition | SYMRISE AG (DE) | 2026-01-27 | — | — | US | claimed |
| US-20230159854-A1 | A FRAGRANCE COMPOSITION | SYMRISE AG (DE) | 2023-05-25 | — | — | US | claimed |
| EP-4149919-A1 | A FRAGRANCE COMPOSITION | Symrise AG (DE) | 2023-03-22 | — | — | EP | claimed |
| CN-115551828-A | Perfume composition | 西姆莱斯股份公司 | 2022-12-30 | — | — | CN | claimed |
| WO-2021228352-A1 | A FRAGRANCE COMPOSITION | SYMRISE AG (DE) | 2021-11-18 | — | — | WO | claimed |
| WO-2021228840-A1 | A FRAGRANCE COMPOSITION | SYMRISE AG (DE) | 2021-11-18 | — | — | WO | claimed |
| US-12534685-B2 | Fragrance composition | SYMRISE AG (DE) | 2026-01-27 | — | — | US | disclosed |
| EP-3604983-B1 | METHOD FOR DETECTING LOCATION OF REFRIGERANT LEAK | DAIKIN IND LTD (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-20230303495-A9 | PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI JEYOU PHARMACEUTICAL CO., LTD. (CN) | 2023-09-28 | — | — | US | disclosed |
| US-20230159854-A1 | A FRAGRANCE COMPOSITION | SYMRISE AG (DE) | 2023-05-25 | — | — | US | disclosed |
| EP-4149919-A1 | A FRAGRANCE COMPOSITION | Symrise AG (DE) | 2023-03-22 | — | — | EP | disclosed |
| US-20230026907-A1 | PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF | ORION CORP (FI) | 2023-01-26 | — | — | US | disclosed |
| CN-115551828-A | Perfume composition | 西姆莱斯股份公司 | 2022-12-30 | — | — | CN | disclosed |
| US-9227978-B2 | Covalent inhibitors of Kras G12C | ARAXES PHARMA LLC (US) | 2016-01-05 | — | — | US | disclosed |
| US-20140288045-A1 | COVALENT INHIBITORS OF KRAS G12C | ARAXES PHARMA LLC | 2014-09-25 | — | — | US | disclosed |
| EP-1518853-B1 | Method for producing alkyl and/or cycloalkyl-substituted cyclic nitrile | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-03-04 | — | — | EP | disclosed |
| WO-2008137102-A2 | METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR | TORREYPINES THERAPEUTICS, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| US-7102025-B2 | Method for producing alkyl and/or cycloalkyl-substituted cyclic nitrile | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-09-05 | — | — | US | disclosed |
| US-20050124823-A1 | Method for producing alkyl and/or cycloalkyl-substituted cyclic nitrile | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-06-09 | — | — | US | disclosed |
| EP-1518853-A1 | Method for producing alkyl and/or cycloalkyl-substituted cyclic nitrile | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-03-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026907-A1 | PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF | SCN11A, HCN4, CACNA1F | TSHR 3349/4885ALDH1A1 1729/4885KMT2A 3925/4885 |
| US-12534685-B2 | Fragrance composition | NCLN, HCN2, TRPA1 | TSHR 3358/4885ALDH1A1 1363/4885KMT2A 2417/4885 |
| US-20140288045-A1 | COVALENT INHIBITORS OF KRAS G12C | KRAS, NRAS, HRAS | TSHR 3799/4885ALDH1A1 2706/4885KMT2A 535/4885 |
| US-20230303495-A9 | PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF | SCN11A, HCN4, CACNA1F | TSHR 3349/4885ALDH1A1 1729/4885KMT2A 3925/4885 |
| US-20230159854-A1 | A FRAGRANCE COMPOSITION | NISCH, NOS1, COXFA4 | TSHR 4764/4885ALDH1A1 438/4885KMT2A 2511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.